Free Trial

IDEXX Laboratories (IDXX) SEC Filings & 10K Form

IDEXX Laboratories logo
$522.70 -4.22 (-0.80%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$523.22 +0.52 (+0.10%)
As of 06/13/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent IDEXX Laboratories SEC Filings

DateFilerForm TypeView
05/23/2025
4:00 PM
IDEXX Laboratories (Issuer)
SZOSTAK M ANNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
6:32 PM
IDEXX Laboratories (Subject)
JUNIUS DANIEL M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2025
3:18 PM
IDEXX Laboratories (Subject)
Vandebroek Sophie V. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2025
3:00 PM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
6:00 PM
Britt Irene Chang (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
6:00 PM
Claflin Bruce L. (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
6:00 PM
ESSIG STUART (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
6:01 PM
IDEXX Laboratories (Issuer)
JUNIUS DANIEL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
6:01 PM
IDEXX Laboratories (Issuer)
Kingsley Lawrence D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
6:01 PM
IDEXX Laboratories (Issuer)
SAMAD SAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
6:01 PM
IDEXX Laboratories (Issuer)
SZOSTAK M ANNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
6:01 PM
IDEXX Laboratories (Issuer)
Vandebroek Sophie V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
3:19 PM
COLLINS Asha (Reporting)
IDEXX Laboratories (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2025
3:11 PM
IDEXX Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2025
5:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
6:12 PM
Emerson Andrew (Reporting)
IDEXX Laboratories (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/21/2025
7:28 AM
IDEXX Laboratories (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/18/2025
8:42 PM
Erickson Michael G (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:42 PM
FENNELL GEORGE (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:43 PM
Hunt Nimrata (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:43 PM
IDEXX Laboratories (Issuer)
Johnson Michael Perkins (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:43 PM
IDEXX Laboratories (Issuer)
Lane Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:43 PM
IDEXX Laboratories (Issuer)
MAZELSKY JONATHAN JAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:43 PM
IDEXX Laboratories (Issuer)
Schreck Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:43 PM
IDEXX Laboratories (Issuer)
Smith Martin Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:44 PM
IDEXX Laboratories (Issuer)
Underberg Sharon E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:44 PM
IDEXX Laboratories (Issuer)
MCKEON BRIAN P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:52 PM
FENNELL GEORGE (Reporting)
IDEXX Laboratories (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2025
3:08 PM
IDEXX Laboratories (Subject)
SZOSTAK M ANNE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
5:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
4:00 PM
Erickson Michael G (Reporting)
IDEXX Laboratories (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
12/09/2024
6:32 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2024
4:00 PM
IDEXX Laboratories (Issuer)
Vandebroek Sophie V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
3:36 PM
IDEXX Laboratories (Subject)
Vandebroek Sophie V. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
6:32 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
2:48 PM
IDEXX Laboratories (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
6:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
10:47 AM
IDEXX Laboratories (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
3:14 PM
IDEXX Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
12:23 PM
IDEXX Laboratories (Filer)
Form 8-K/A
10/31/2024
5:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Gold is soaring. Here’s how to get paid from it (Ad)

Gold just broke through $3,300… And while the headlines shout about price targets, something even more powerful is happening behind the scenes… Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. No trading gold futures. No mining stocks. No vaults. Just a simple fund delivering monthly payouts — like clockwork.

Click here to discover the income ETF behind it all.
09/09/2024
3:18 PM
IDEXX Laboratories (Issuer)
SZOSTAK M ANNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
3:20 PM
AYERS JONATHAN W (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
3:36 PM
IDEXX Laboratories (Subject)
SZOSTAK M ANNE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
7:20 PM
IDEXX Laboratories (Issuer)
Schreck Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:03 PM
IDEXX Laboratories (Issuer)
Smith Martin Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IDXX) was last updated on 6/15/2025 by MarketBeat.com Staff
From Our Partners